Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
JAMA Oncol
; 5(2): 236-242, 2019 02 01.
Article
in En
| MEDLINE
| ID: mdl-30489611
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Drug Costs
/
Capecitabine
/
Bevacizumab
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA Oncol
Year:
2019
Document type:
Article
Country of publication: